

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | interferon-gamma production (GO:0032609) | 6.30980399 |
| 2 | negative regulation of execution phase of apoptosis (GO:1900118) | 6.13258567 |
| 3 | L-alpha-amino acid transmembrane transport (GO:1902475) | 5.27729229 |
| 4 | cellular ketone body metabolic process (GO:0046950) | 5.02741944 |
| 5 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 4.80618529 |
| 6 | leukocyte aggregation (GO:0070486) | 4.78499101 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.70251059 |
| 8 | macroautophagy (GO:0016236) | 4.66915842 |
| 9 | epithelial cell fate commitment (GO:0072148) | 4.61836281 |
| 10 | regulation of extracellular matrix disassembly (GO:0010715) | 4.57047709 |
| 11 | glycerophospholipid catabolic process (GO:0046475) | 4.54101792 |
| 12 | insulin secretion (GO:0030073) | 4.45242350 |
| 13 | ketone body metabolic process (GO:1902224) | 4.42142203 |
| 14 | positive regulation of gluconeogenesis (GO:0045722) | 4.37470255 |
| 15 | peptide hormone processing (GO:0016486) | 4.35118311 |
| 16 | respiratory chain complex IV assembly (GO:0008535) | 4.30035176 |
| 17 | T cell migration (GO:0072678) | 4.22893161 |
| 18 | inositol phosphate catabolic process (GO:0071545) | 4.22243673 |
| 19 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.17972850 |
| 20 | signal peptide processing (GO:0006465) | 4.16549862 |
| 21 | positive thymic T cell selection (GO:0045059) | 4.14447556 |
| 22 | positive T cell selection (GO:0043368) | 4.11253712 |
| 23 | sphingomyelin metabolic process (GO:0006684) | 4.03883731 |
| 24 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.01950352 |
| 25 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.99420701 |
| 26 | inositol phosphate dephosphorylation (GO:0046855) | 3.99420701 |
| 27 | nitric oxide biosynthetic process (GO:0006809) | 3.93503432 |
| 28 | regulation of autophagic vacuole assembly (GO:2000785) | 3.92053990 |
| 29 | cytochrome complex assembly (GO:0017004) | 3.91615591 |
| 30 | regulation of glucokinase activity (GO:0033131) | 3.88602725 |
| 31 | regulation of hexokinase activity (GO:1903299) | 3.88602725 |
| 32 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.87732075 |
| 33 | endocrine pancreas development (GO:0031018) | 3.87075581 |
| 34 | adult feeding behavior (GO:0008343) | 3.81155244 |
| 35 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.77090506 |
| 36 | cellular response to zinc ion (GO:0071294) | 3.72296584 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.64830894 |
| 38 | DNA strand renaturation (GO:0000733) | 3.62589495 |
| 39 | auditory receptor cell differentiation (GO:0042491) | 3.60452820 |
| 40 | regulation of vacuole organization (GO:0044088) | 3.58122896 |
| 41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.54833999 |
| 42 | L-phenylalanine catabolic process (GO:0006559) | 3.54833999 |
| 43 | startle response (GO:0001964) | 3.52684208 |
| 44 | negative regulation of complement activation (GO:0045916) | 3.52535662 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.52259131 |
| 46 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.51432953 |
| 47 | cellular response to interleukin-15 (GO:0071350) | 3.50830651 |
| 48 | regulation of execution phase of apoptosis (GO:1900117) | 3.50353640 |
| 49 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.46590429 |
| 50 | regulation of Rac protein signal transduction (GO:0035020) | 3.45374997 |
| 51 | somite rostral/caudal axis specification (GO:0032525) | 3.44386127 |
| 52 | superoxide anion generation (GO:0042554) | 3.42132443 |
| 53 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.41184297 |
| 54 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.38380509 |
| 55 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.36189436 |
| 56 | toxin transport (GO:1901998) | 3.34902854 |
| 57 | replication fork processing (GO:0031297) | 3.33805212 |
| 58 | positive regulation of insulin secretion (GO:0032024) | 3.33372233 |
| 59 | positive regulation of response to extracellular stimulus (GO:0032106) | 3.32518525 |
| 60 | positive regulation of response to nutrient levels (GO:0032109) | 3.32518525 |
| 61 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.31304824 |
| 62 | negative T cell selection (GO:0043383) | 3.30013591 |
| 63 | negative regulation of protein activation cascade (GO:2000258) | 3.16899373 |
| 64 | polyol catabolic process (GO:0046174) | 3.14983556 |
| 65 | positive regulation of neutrophil migration (GO:1902624) | 3.14272657 |
| 66 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.14272657 |
| 67 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.11820869 |
| 68 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.11710500 |
| 69 | catecholamine transport (GO:0051937) | 3.11413553 |
| 70 | nephron tubule morphogenesis (GO:0072078) | 3.10990597 |
| 71 | nephron epithelium morphogenesis (GO:0072088) | 3.10990597 |
| 72 | phospholipid catabolic process (GO:0009395) | 3.10914908 |
| 73 | protein localization to Golgi apparatus (GO:0034067) | 3.10560236 |
| 74 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.09206181 |
| 75 | L-phenylalanine metabolic process (GO:0006558) | 3.09206181 |
| 76 | leukocyte cell-cell adhesion (GO:0007159) | 3.09074814 |
| 77 | mast cell activation (GO:0045576) | 3.08988551 |
| 78 | negative regulation of T cell mediated immunity (GO:0002710) | 3.08303492 |
| 79 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.07928490 |
| 80 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.07842621 |
| 81 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.07842621 |
| 82 | positive regulation of B cell mediated immunity (GO:0002714) | 3.07410759 |
| 83 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.07410759 |
| 84 | toxin metabolic process (GO:0009404) | 3.07204096 |
| 85 | basic amino acid transport (GO:0015802) | 3.07071325 |
| 86 | negative regulation of cell killing (GO:0031342) | 3.04443322 |
| 87 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.04443322 |
| 88 | positive regulation of interleukin-12 production (GO:0032735) | 3.04236333 |
| 89 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.04025029 |
| 90 | negative thymic T cell selection (GO:0045060) | 3.03942075 |
| 91 | negative regulation of viral genome replication (GO:0045071) | 3.03429524 |
| 92 | protein targeting to Golgi (GO:0000042) | 3.02872930 |
| 93 | polyketide metabolic process (GO:0030638) | 3.01288123 |
| 94 | doxorubicin metabolic process (GO:0044598) | 3.01288123 |
| 95 | daunorubicin metabolic process (GO:0044597) | 3.01288123 |
| 96 | aromatic amino acid family catabolic process (GO:0009074) | 3.01120537 |
| 97 | positive regulation of macroautophagy (GO:0016239) | 2.97334616 |
| 98 | response to peptidoglycan (GO:0032494) | 2.97298702 |
| 99 | neutrophil activation involved in immune response (GO:0002283) | 2.96891002 |
| 100 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.96196408 |
| 101 | establishment of protein localization to Golgi (GO:0072600) | 2.95387206 |
| 102 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.94822588 |
| 103 | response to pheromone (GO:0019236) | 2.94321213 |
| 104 | sphingolipid catabolic process (GO:0030149) | 2.93228786 |
| 105 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.92951156 |
| 106 | peptide hormone secretion (GO:0030072) | 2.92828486 |
| 107 | glandular epithelial cell differentiation (GO:0002067) | 2.90563116 |
| 108 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.90293637 |
| 109 | positive regulation of calcium ion import (GO:0090280) | 2.87697789 |
| 110 | detection of calcium ion (GO:0005513) | 2.87495055 |
| 111 | G-protein coupled receptor internalization (GO:0002031) | 2.87156331 |
| 112 | alanine transport (GO:0032328) | 2.85726645 |
| 113 | peptide secretion (GO:0002790) | 2.84821873 |
| 114 | regulation of respiratory burst (GO:0060263) | 2.84217682 |
| 115 | potassium ion export (GO:0071435) | 2.83768940 |
| 116 | protein complex biogenesis (GO:0070271) | 2.83653375 |
| 117 | regulation of RIG-I signaling pathway (GO:0039535) | 2.82885111 |
| 118 | organic cation transport (GO:0015695) | 2.81388362 |
| 119 | early endosome to late endosome transport (GO:0045022) | 2.81320139 |
| 120 | immunoglobulin mediated immune response (GO:0016064) | 2.81161587 |
| 121 | dopamine transport (GO:0015872) | 2.79510525 |
| 122 | regulation of activation of Janus kinase activity (GO:0010533) | 2.79406500 |
| 123 | regulation of neurotransmitter uptake (GO:0051580) | 2.79313310 |
| 124 | T cell receptor signaling pathway (GO:0050852) | 2.78980643 |
| 125 | positive regulation of antigen processing and presentation (GO:0002579) | 2.78563294 |
| 126 | B cell mediated immunity (GO:0019724) | 2.77613162 |
| 127 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.77475561 |
| 128 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.76628828 |
| 129 | regulation of immunoglobulin secretion (GO:0051023) | 2.76106974 |
| 130 | phenylpropanoid metabolic process (GO:0009698) | 2.75962643 |
| 131 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.72423995 |
| 132 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.71658985 |
| 133 | nitric oxide mediated signal transduction (GO:0007263) | 2.71246904 |
| 134 | retinol metabolic process (GO:0042572) | 2.70692637 |
| 135 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.70637020 |
| 136 | cellular response to exogenous dsRNA (GO:0071360) | 2.70115758 |
| 137 | positive regulation of isotype switching (GO:0045830) | 2.70058063 |
| 138 | eosinophil chemotaxis (GO:0048245) | 2.69704010 |
| 139 | regulation of neutrophil migration (GO:1902622) | 2.69232583 |
| 140 | regulation of neutrophil chemotaxis (GO:0090022) | 2.69232583 |
| 141 | negative regulation of humoral immune response (GO:0002921) | 2.68955293 |
| 142 | regulation of insulin secretion (GO:0050796) | 2.67987247 |
| 143 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.67862127 |
| 144 | type I interferon signaling pathway (GO:0060337) | 2.67695596 |
| 145 | cellular response to type I interferon (GO:0071357) | 2.67695596 |
| 146 | renal tubule morphogenesis (GO:0061333) | 2.67591677 |
| 147 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.67366836 |
| 148 | brain morphogenesis (GO:0048854) | 2.67131052 |
| 149 | protein polyglutamylation (GO:0018095) | 2.66999304 |
| 150 | positive regulation of DNA recombination (GO:0045911) | 2.66959327 |
| 151 | reverse cholesterol transport (GO:0043691) | 2.65529059 |
| 152 | positive regulation of defense response to virus by host (GO:0002230) | 2.65402017 |
| 153 | lactate metabolic process (GO:0006089) | 2.65399752 |
| 154 | T cell selection (GO:0045058) | 2.65262236 |
| 155 | nodal signaling pathway (GO:0038092) | 2.65206024 |
| 156 | response to type I interferon (GO:0034340) | 2.64330069 |
| 157 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.63965525 |
| 158 | single strand break repair (GO:0000012) | 2.62674141 |
| 159 | amyloid precursor protein catabolic process (GO:0042987) | 2.62553108 |
| 160 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.62110408 |
| 161 | adaptation of signaling pathway (GO:0023058) | 2.61421220 |
| 162 | membrane lipid catabolic process (GO:0046466) | 2.61265317 |
| 163 | C-terminal protein lipidation (GO:0006501) | 2.60942408 |
| 164 | regulation of T cell chemotaxis (GO:0010819) | 2.60292836 |
| 165 | positive regulation of T cell chemotaxis (GO:0010820) | 2.60292836 |
| 166 | axoneme assembly (GO:0035082) | 2.59846636 |
| 167 | positive regulation of peptide hormone secretion (GO:0090277) | 2.59833866 |
| 168 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.59612660 |
| 169 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.59612660 |
| 170 | calcium ion-dependent exocytosis (GO:0017156) | 2.59540863 |
| 171 | positive regulation of macrophage differentiation (GO:0045651) | 2.59332751 |
| 172 | regulation of cilium movement (GO:0003352) | 2.59007824 |
| 173 | zinc ion homeostasis (GO:0055069) | 2.58745234 |
| 174 | B cell proliferation (GO:0042100) | 2.58415823 |
| 175 | regulation of mitochondrial translation (GO:0070129) | 2.55266014 |
| 176 | positive regulation of interleukin-17 production (GO:0032740) | 2.54764016 |
| 177 | sperm motility (GO:0030317) | 2.54752208 |
| 178 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.54410813 |
| 179 | positive regulation of neurotransmitter transport (GO:0051590) | 2.54200758 |
| 180 | regulation of B cell mediated immunity (GO:0002712) | 2.53837837 |
| 181 | thymic T cell selection (GO:0045061) | 2.52790187 |
| 182 | regulation of sister chromatid cohesion (GO:0007063) | 2.52326252 |
| 183 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.51946958 |
| 184 | natural killer cell activation (GO:0030101) | 2.51683673 |
| 185 | regulation of antigen processing and presentation (GO:0002577) | 2.51634608 |
| 186 | regulation of T-helper 1 type immune response (GO:0002825) | 2.51236162 |
| 187 | detection of other organism (GO:0098543) | 2.50369291 |
| 188 | positive regulation of developmental pigmentation (GO:0048087) | 2.47646393 |
| 189 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.47353017 |
| 190 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.45876209 |
| 191 | regulation of gamma-delta T cell activation (GO:0046643) | 2.45333594 |
| 192 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.42970349 |
| 193 | response to protozoan (GO:0001562) | 2.42689537 |
| 194 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.41967517 |
| 195 | defense response to protozoan (GO:0042832) | 2.41898100 |
| 196 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.41680054 |
| 197 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.41443313 |
| 198 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.39765196 |
| 199 | myeloid dendritic cell activation (GO:0001773) | 2.39756325 |
| 200 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.39593807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 7.19908306 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.66077787 |
| 3 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.51180033 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.43831001 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.30426607 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.17529924 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.14152790 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 4.11622354 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.79887353 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.39363232 |
| 11 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 3.31664869 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.30115727 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.11613023 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.07832038 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.96190161 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.93007240 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.81212805 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.64704818 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.55221819 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.36873342 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.27630617 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19689461 |
| 23 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.17601496 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.08443550 |
| 25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.94960422 |
| 26 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.94816328 |
| 27 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.94564653 |
| 28 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.93438086 |
| 29 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.93438086 |
| 30 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.93438086 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.89938009 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88186702 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.83630037 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.81680772 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80350840 |
| 36 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.80260692 |
| 37 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.77471415 |
| 38 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.74627334 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.72181083 |
| 40 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.71342383 |
| 41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.70556930 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.69703480 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.69244997 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.67084697 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66567296 |
| 46 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.62860045 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.61625918 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61018366 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60823910 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60163604 |
| 51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.59484321 |
| 52 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.56858116 |
| 53 | * MYB_26560356_Chip-Seq_TH1_Human | 1.56789893 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.55262942 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53605700 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53531027 |
| 57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.53208642 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.51960081 |
| 59 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.51638524 |
| 60 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.49461941 |
| 61 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.48521713 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.46855136 |
| 63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.43988584 |
| 64 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.42890340 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.41892403 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39973391 |
| 67 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39515061 |
| 68 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.38031187 |
| 69 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.38031187 |
| 70 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.35483090 |
| 71 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.34738302 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.33928605 |
| 73 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.33928605 |
| 74 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.32919110 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31995457 |
| 76 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.30267922 |
| 77 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.29327230 |
| 78 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.28820332 |
| 79 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.27512001 |
| 80 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.27508766 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27368516 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26435189 |
| 83 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.26369023 |
| 84 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.25496776 |
| 85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23519621 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23274299 |
| 87 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.22690550 |
| 88 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.21541228 |
| 89 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.21541228 |
| 90 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.19718036 |
| 91 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18541383 |
| 92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18473595 |
| 93 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17193412 |
| 94 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17059327 |
| 95 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.16412049 |
| 96 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14607267 |
| 97 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14335031 |
| 98 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13932979 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13898406 |
| 100 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13146782 |
| 101 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12303258 |
| 102 | AR_20517297_ChIP-Seq_VCAP_Human | 1.11870379 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11846126 |
| 104 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.11769955 |
| 105 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11454039 |
| 106 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11136765 |
| 107 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11033365 |
| 108 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.10903874 |
| 109 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.10594983 |
| 110 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10228625 |
| 111 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09000174 |
| 112 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.08431624 |
| 113 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07967242 |
| 114 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06819938 |
| 115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06764970 |
| 116 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.06602554 |
| 117 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06451140 |
| 118 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.06371788 |
| 119 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06233963 |
| 120 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04660940 |
| 121 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03515754 |
| 122 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03045461 |
| 123 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03016055 |
| 124 | NCOR_22424771_ChIP-Seq_293T_Human | 1.02975758 |
| 125 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.02562571 |
| 126 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02251908 |
| 127 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.02066112 |
| 128 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.01402496 |
| 129 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.01209940 |
| 130 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.01199219 |
| 131 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00999734 |
| 132 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00959196 |
| 133 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00609641 |
| 134 | * MAF_26560356_Chip-Seq_TH1_Human | 1.00092988 |
| 135 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.99877444 |
| 136 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.99790081 |
| 137 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.98888589 |
| 138 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98888487 |
| 139 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98082781 |
| 140 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97533913 |
| 141 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97447156 |
| 142 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.96807129 |
| 143 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95691930 |
| 144 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.95429196 |
| 145 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95214218 |
| 146 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.94889887 |
| 147 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93785375 |
| 148 | TBL1_22424771_ChIP-Seq_293T_Human | 0.93222268 |
| 149 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92355294 |
| 150 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.91611726 |
| 151 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91597225 |
| 152 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.91139056 |
| 153 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90541954 |
| 154 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.90413025 |
| 155 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90137945 |
| 156 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.87543613 |
| 157 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87058497 |
| 158 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.86902329 |
| 159 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.86289300 |
| 160 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.85732779 |
| 161 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.84949702 |
| 162 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84946737 |
| 163 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.84096544 |
| 164 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.83088866 |
| 165 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82180767 |
| 166 | EWS_26573619_Chip-Seq_HEK293_Human | 0.81847453 |
| 167 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.81716657 |
| 168 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.81173745 |
| 169 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81089287 |
| 170 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79975316 |
| 171 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.79909453 |
| 172 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.79676376 |
| 173 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78346827 |
| 174 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.77687577 |
| 175 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.76619344 |
| 176 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.76002658 |
| 177 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.75308314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.52127664 |
| 2 | MP0005379_endocrine/exocrine_gland_phen | 4.39847380 |
| 3 | MP0009785_altered_susceptibility_to | 3.74785978 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.39058214 |
| 5 | MP0002909_abnormal_adrenal_gland | 3.37181616 |
| 6 | MP0000685_abnormal_immune_system | 3.27936030 |
| 7 | MP0006082_CNS_inflammation | 3.27870772 |
| 8 | MP0002254_reproductive_system_inflammat | 3.25223530 |
| 9 | MP0005645_abnormal_hypothalamus_physiol | 3.10758620 |
| 10 | MP0000013_abnormal_adipose_tissue | 2.99283169 |
| 11 | MP0005671_abnormal_response_to | 2.92756241 |
| 12 | MP0002163_abnormal_gland_morphology | 2.92461190 |
| 13 | MP0008057_abnormal_DNA_replication | 2.85459932 |
| 14 | MP0006292_abnormal_olfactory_placode | 2.84686451 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.79044401 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.67281694 |
| 17 | MP0003195_calcinosis | 2.67077539 |
| 18 | MP0005387_immune_system_phenotype | 2.64554696 |
| 19 | MP0001790_abnormal_immune_system | 2.64554696 |
| 20 | MP0003136_yellow_coat_color | 2.63422398 |
| 21 | MP0001944_abnormal_pancreas_morphology | 2.63294308 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.61560855 |
| 23 | MP0003724_increased_susceptibility_to | 2.58639774 |
| 24 | MP0010329_abnormal_lipoprotein_level | 2.57366644 |
| 25 | MP0002277_abnormal_respiratory_mucosa | 2.53507564 |
| 26 | MP0005025_abnormal_response_to | 2.51411127 |
| 27 | MP0003763_abnormal_thymus_physiology | 2.45297239 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 2.41941123 |
| 29 | MP0004264_abnormal_extraembryonic_tissu | 2.38939489 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 2.35384682 |
| 31 | MP0003436_decreased_susceptibility_to | 2.31992407 |
| 32 | MP0004270_analgesia | 2.27460251 |
| 33 | MP0006072_abnormal_retinal_apoptosis | 2.24567424 |
| 34 | MP0001800_abnormal_humoral_immune | 2.18008928 |
| 35 | MP0003172_abnormal_lysosome_physiology | 2.14751463 |
| 36 | MP0002723_abnormal_immune_serum | 2.07580549 |
| 37 | MP0001819_abnormal_immune_cell | 2.04497629 |
| 38 | MP0005310_abnormal_salivary_gland | 2.02609140 |
| 39 | MP0002420_abnormal_adaptive_immunity | 2.00178967 |
| 40 | MP0005075_abnormal_melanosome_morpholog | 1.92209367 |
| 41 | MP0003693_abnormal_embryo_hatching | 1.89645228 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.87541074 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.85970839 |
| 44 | MP0003121_genomic_imprinting | 1.85779612 |
| 45 | MP0005248_abnormal_Harderian_gland | 1.85759295 |
| 46 | MP0003122_maternal_imprinting | 1.81616308 |
| 47 | MP0002398_abnormal_bone_marrow | 1.80724559 |
| 48 | MP0005332_abnormal_amino_acid | 1.80587464 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.75019422 |
| 50 | MP0009046_muscle_twitch | 1.74899775 |
| 51 | MP0003890_abnormal_embryonic-extraembry | 1.73445887 |
| 52 | * MP0002078_abnormal_glucose_homeostasis | 1.69665658 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.68244946 |
| 54 | MP0000858_altered_metastatic_potential | 1.67926671 |
| 55 | MP0000716_abnormal_immune_system | 1.67569978 |
| 56 | MP0005171_absent_coat_pigmentation | 1.65188640 |
| 57 | MP0005365_abnormal_bile_salt | 1.63525990 |
| 58 | MP0001501_abnormal_sleep_pattern | 1.59871317 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.59801285 |
| 60 | MP0000490_abnormal_crypts_of | 1.58873557 |
| 61 | MP0001756_abnormal_urination | 1.57438168 |
| 62 | MP0002419_abnormal_innate_immunity | 1.56259750 |
| 63 | MP0004782_abnormal_surfactant_physiolog | 1.56057310 |
| 64 | MP0004043_abnormal_pH_regulation | 1.55564176 |
| 65 | MP0003077_abnormal_cell_cycle | 1.54812485 |
| 66 | MP0000003_abnormal_adipose_tissue | 1.52996059 |
| 67 | MP0002405_respiratory_system_inflammati | 1.51955516 |
| 68 | MP0004381_abnormal_hair_follicle | 1.51031563 |
| 69 | MP0009764_decreased_sensitivity_to | 1.49908040 |
| 70 | MP0010386_abnormal_urinary_bladder | 1.46583830 |
| 71 | MP0002638_abnormal_pupillary_reflex | 1.41326525 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.40616844 |
| 73 | MP0000372_irregular_coat_pigmentation | 1.39422360 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.37342699 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 1.37342699 |
| 76 | MP0002429_abnormal_blood_cell | 1.35089783 |
| 77 | MP0002722_abnormal_immune_system | 1.33839205 |
| 78 | MP0002736_abnormal_nociception_after | 1.32016851 |
| 79 | MP0001765_abnormal_ion_homeostasis | 1.30080673 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.29787027 |
| 81 | MP0004947_skin_inflammation | 1.29659765 |
| 82 | MP0000703_abnormal_thymus_morphology | 1.29214481 |
| 83 | MP0002090_abnormal_vision | 1.27911426 |
| 84 | MP0003123_paternal_imprinting | 1.27505495 |
| 85 | MP0009840_abnormal_foam_cell | 1.26572995 |
| 86 | * MP0005448_abnormal_energy_balance | 1.25828504 |
| 87 | MP0005410_abnormal_fertilization | 1.24929659 |
| 88 | MP0001905_abnormal_dopamine_level | 1.24624398 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 1.23765752 |
| 90 | MP0003787_abnormal_imprinting | 1.23495933 |
| 91 | MP0010094_abnormal_chromosome_stability | 1.23432937 |
| 92 | MP0003011_delayed_dark_adaptation | 1.23219775 |
| 93 | MP0009745_abnormal_behavioral_response | 1.22402009 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 1.21594266 |
| 95 | MP0004957_abnormal_blastocyst_morpholog | 1.21546603 |
| 96 | MP0003111_abnormal_nucleus_morphology | 1.19761413 |
| 97 | MP0000689_abnormal_spleen_morphology | 1.19431618 |
| 98 | MP0001845_abnormal_inflammatory_respons | 1.18383268 |
| 99 | MP0002396_abnormal_hematopoietic_system | 1.16637969 |
| 100 | MP0002132_abnormal_respiratory_system | 1.16068131 |
| 101 | MP0002295_abnormal_pulmonary_circulatio | 1.15270721 |
| 102 | * MP0003953_abnormal_hormone_level | 1.14595420 |
| 103 | MP0002064_seizures | 1.13592839 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 1.13344737 |
| 105 | MP0005535_abnormal_body_temperature | 1.11427148 |
| 106 | MP0002971_abnormal_brown_adipose | 1.10015107 |
| 107 | MP0003943_abnormal_hepatobiliary_system | 1.09434519 |
| 108 | MP0001188_hyperpigmentation | 1.08248959 |
| 109 | MP0001853_heart_inflammation | 1.07635665 |
| 110 | MP0002938_white_spotting | 1.06951518 |
| 111 | MP0003880_abnormal_central_pattern | 1.05999737 |
| 112 | MP0003828_pulmonary_edema | 1.05577217 |
| 113 | MP0002733_abnormal_thermal_nociception | 1.04489669 |
| 114 | MP0001502_abnormal_circadian_rhythm | 1.04407603 |
| 115 | MP0004133_heterotaxia | 1.03218202 |
| 116 | MP0004885_abnormal_endolymph | 1.02993812 |
| 117 | MP0002118_abnormal_lipid_homeostasis | 1.02860959 |
| 118 | MP0003633_abnormal_nervous_system | 1.02857445 |
| 119 | MP0000639_abnormal_adrenal_gland | 1.02372278 |
| 120 | MP0000427_abnormal_hair_cycle | 1.02338015 |
| 121 | MP0003448_altered_tumor_morphology | 1.01737368 |
| 122 | MP0008058_abnormal_DNA_repair | 1.01419746 |
| 123 | MP0005451_abnormal_body_composition | 0.99721216 |
| 124 | MP0003866_abnormal_defecation | 0.99128202 |
| 125 | MP0008004_abnormal_stomach_pH | 0.97575690 |
| 126 | MP0008932_abnormal_embryonic_tissue | 0.97313509 |
| 127 | MP0005257_abnormal_intraocular_pressure | 0.97290532 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.95596930 |
| 129 | MP0010234_abnormal_vibrissa_follicle | 0.94896441 |
| 130 | MP0004085_abnormal_heartbeat | 0.94210704 |
| 131 | MP0005058_abnormal_lysosome_morphology | 0.93919024 |
| 132 | MP0003879_abnormal_hair_cell | 0.93710955 |
| 133 | MP0002734_abnormal_mechanical_nocicepti | 0.93485546 |
| 134 | MP0002928_abnormal_bile_duct | 0.93148871 |
| 135 | MP0004215_abnormal_myocardial_fiber | 0.92144528 |
| 136 | MP0001533_abnormal_skeleton_physiology | 0.92055917 |
| 137 | MP0002229_neurodegeneration | 0.91933059 |
| 138 | MP0000631_abnormal_neuroendocrine_gland | 0.90049121 |
| 139 | MP0000230_abnormal_systemic_arterial | 0.89946191 |
| 140 | MP0002272_abnormal_nervous_system | 0.89902602 |
| 141 | MP0000569_abnormal_digit_pigmentation | 0.88925064 |
| 142 | MP0002019_abnormal_tumor_incidence | 0.88100684 |
| 143 | MP0002557_abnormal_social/conspecific_i | 0.87675271 |
| 144 | MP0001970_abnormal_pain_threshold | 0.87652519 |
| 145 | MP0005367_renal/urinary_system_phenotyp | 0.87467508 |
| 146 | MP0000516_abnormal_urinary_system | 0.87467508 |
| 147 | MP0005464_abnormal_platelet_physiology | 0.87297538 |
| 148 | MP0001968_abnormal_touch/_nociception | 0.86270713 |
| 149 | MP0008961_abnormal_basal_metabolism | 0.86177768 |
| 150 | MP0008872_abnormal_physiological_respon | 0.85400725 |
| 151 | MP0002009_preneoplasia | 0.84363373 |
| 152 | MP0005085_abnormal_gallbladder_physiolo | 0.83065344 |
| 153 | * MP0002069_abnormal_eating/drinking_beha | 0.82829120 |
| 154 | MP0002006_tumorigenesis | 0.82776558 |
| 155 | MP0009643_abnormal_urine_homeostasis | 0.82700795 |
| 156 | MP0003252_abnormal_bile_duct | 0.80938855 |
| 157 | MP0003786_premature_aging | 0.80687528 |
| 158 | MP0000613_abnormal_salivary_gland | 0.80358358 |
| 159 | MP0002098_abnormal_vibrissa_morphology | 0.80110253 |
| 160 | MP0010307_abnormal_tumor_latency | 0.79786088 |
| 161 | MP0003959_abnormal_lean_body | 0.79644437 |
| 162 | MP0005390_skeleton_phenotype | 0.79414876 |
| 163 | MP0003283_abnormal_digestive_organ | 0.76514781 |
| 164 | MP0002693_abnormal_pancreas_physiology | 0.76282231 |
| 165 | MP0002160_abnormal_reproductive_system | 0.75490351 |
| 166 | MP0002138_abnormal_hepatobiliary_system | 0.74788338 |
| 167 | MP0002572_abnormal_emotion/affect_behav | 0.72831746 |
| 168 | MP0008469_abnormal_protein_level | 0.72319409 |
| 169 | MP0005253_abnormal_eye_physiology | 0.72201270 |
| 170 | MP0006035_abnormal_mitochondrial_morpho | 0.72134195 |
| 171 | * MP0005452_abnormal_adipose_tissue | 0.72091690 |
| 172 | MP0001486_abnormal_startle_reflex | 0.70181828 |
| 173 | MP0001485_abnormal_pinna_reflex | 0.69788176 |
| 174 | MP0005386_behavior/neurological_phenoty | 0.69774891 |
| 175 | MP0004924_abnormal_behavior | 0.69774891 |
| 176 | MP0000538_abnormal_urinary_bladder | 0.69244787 |
| 177 | MP0008995_early_reproductive_senescence | 0.68205365 |
| 178 | MP0006054_spinal_hemorrhage | 0.68023714 |
| 179 | MP0005220_abnormal_exocrine_pancreas | 0.67458707 |
| 180 | MP0000470_abnormal_stomach_morphology | 0.67202831 |
| 181 | MP0000627_abnormal_mammary_gland | 0.66656454 |
| 182 | MP0003045_fibrosis | 0.65915998 |
| 183 | MP0009278_abnormal_bone_marrow | 0.64645262 |
| 184 | MP0005084_abnormal_gallbladder_morpholo | 0.63172430 |
| 185 | MP0000343_altered_response_to | 0.62548714 |
| 186 | MP0008007_abnormal_cellular_replicative | 0.62383613 |
| 187 | MP0004808_abnormal_hematopoietic_stem | 0.62067723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgM level (HP:0003496) | 7.81517716 |
| 2 | Stomatitis (HP:0010280) | 5.21980244 |
| 3 | Large for gestational age (HP:0001520) | 5.04002432 |
| 4 | Intestinal atresia (HP:0011100) | 4.79356951 |
| 5 | Congenital malformation of the right heart (HP:0011723) | 4.70061185 |
| 6 | Double outlet right ventricle (HP:0001719) | 4.70061185 |
| 7 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.47785575 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.19974674 |
| 9 | Autoimmune hemolytic anemia (HP:0001890) | 4.06900856 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.01615607 |
| 11 | Increased CSF protein (HP:0002922) | 4.00112824 |
| 12 | Chromsome breakage (HP:0040012) | 3.96498580 |
| 13 | Hyperglycemia (HP:0003074) | 3.91665422 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 3.85494872 |
| 15 | Vascular calcification (HP:0004934) | 3.50619717 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.41423546 |
| 17 | Meckel diverticulum (HP:0002245) | 3.41228911 |
| 18 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.39228072 |
| 19 | IgG deficiency (HP:0004315) | 3.35045560 |
| 20 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.34233808 |
| 21 | Ketoacidosis (HP:0001993) | 3.31008430 |
| 22 | Abnormality of the ileum (HP:0001549) | 3.29511175 |
| 23 | Gingivitis (HP:0000230) | 3.28775145 |
| 24 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.24839448 |
| 25 | Progressive neurologic deterioration (HP:0002344) | 3.22680823 |
| 26 | Hypothermia (HP:0002045) | 3.16755826 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.15745202 |
| 28 | Abnormality of the preputium (HP:0100587) | 3.15218223 |
| 29 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.15206508 |
| 30 | T lymphocytopenia (HP:0005403) | 3.09547269 |
| 31 | Abnormality of T cell number (HP:0011839) | 3.09236038 |
| 32 | Abnormality of vitamin B metabolism (HP:0004340) | 3.01088789 |
| 33 | Cardiovascular calcification (HP:0011915) | 2.99111543 |
| 34 | Combined immunodeficiency (HP:0005387) | 2.95155499 |
| 35 | Nasal polyposis (HP:0100582) | 2.91594779 |
| 36 | Abnormal ciliary motility (HP:0012262) | 2.91424499 |
| 37 | Orchitis (HP:0100796) | 2.88523689 |
| 38 | Hemiparesis (HP:0001269) | 2.88410534 |
| 39 | Myositis (HP:0100614) | 2.84289918 |
| 40 | Postural tremor (HP:0002174) | 2.84075930 |
| 41 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.83419290 |
| 42 | Hypoplasia of the fovea (HP:0007750) | 2.83419290 |
| 43 | Hypoalbuminemia (HP:0003073) | 2.82416096 |
| 44 | Abnormal albumin level (HP:0012116) | 2.82416096 |
| 45 | Abnormality of chromosome stability (HP:0003220) | 2.76624029 |
| 46 | Congenital sensorineural hearing impairment (HP:0008527) | 2.76226882 |
| 47 | Chronic sinusitis (HP:0011109) | 2.74646178 |
| 48 | Agitation (HP:0000713) | 2.73360251 |
| 49 | Glycosuria (HP:0003076) | 2.72221388 |
| 50 | Abnormality of urine glucose concentration (HP:0011016) | 2.72221388 |
| 51 | Severe Myopia (HP:0011003) | 2.69885717 |
| 52 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.68386037 |
| 53 | Recurrent bronchitis (HP:0002837) | 2.67854846 |
| 54 | Occipital encephalocele (HP:0002085) | 2.65969235 |
| 55 | Hypergammaglobulinemia (HP:0010702) | 2.65091440 |
| 56 | Optic neuritis (HP:0100653) | 2.63709020 |
| 57 | Retrobulbar optic neuritis (HP:0100654) | 2.63709020 |
| 58 | Severe combined immunodeficiency (HP:0004430) | 2.63592401 |
| 59 | Medial flaring of the eyebrow (HP:0010747) | 2.62063814 |
| 60 | Abnormality of T cells (HP:0002843) | 2.61974838 |
| 61 | Cheilitis (HP:0100825) | 2.60631359 |
| 62 | Severe visual impairment (HP:0001141) | 2.60590095 |
| 63 | Clubbing of toes (HP:0100760) | 2.58850992 |
| 64 | Recurrent abscess formation (HP:0002722) | 2.58630304 |
| 65 | Renal cortical cysts (HP:0000803) | 2.58399948 |
| 66 | 3-Methylglutaconic aciduria (HP:0003535) | 2.56871749 |
| 67 | Hypokinesia (HP:0002375) | 2.55552598 |
| 68 | Nephronophthisis (HP:0000090) | 2.54370628 |
| 69 | Obstructive lung disease (HP:0006536) | 2.54037413 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.54037413 |
| 71 | Ketosis (HP:0001946) | 2.50916074 |
| 72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.50606368 |
| 73 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.50606368 |
| 74 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.50606368 |
| 75 | Mucopolysacchariduria (HP:0008155) | 2.46230921 |
| 76 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.46230921 |
| 77 | Abnormality of dental color (HP:0011073) | 2.44809901 |
| 78 | Recurrent fungal infections (HP:0002841) | 2.44155007 |
| 79 | IgA deficiency (HP:0002720) | 2.42707119 |
| 80 | Chronic otitis media (HP:0000389) | 2.41468787 |
| 81 | Abnormality of the fovea (HP:0000493) | 2.36767987 |
| 82 | Aplastic anemia (HP:0001915) | 2.36353432 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.36010141 |
| 84 | Acute necrotizing encephalopathy (HP:0006965) | 2.34533769 |
| 85 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.34035518 |
| 86 | Progressive macrocephaly (HP:0004481) | 2.33475033 |
| 87 | Orthostatic hypotension (HP:0001278) | 2.30267327 |
| 88 | Attenuation of retinal blood vessels (HP:0007843) | 2.29787993 |
| 89 | Hypochromic anemia (HP:0001931) | 2.29493259 |
| 90 | Prolonged partial thromboplastin time (HP:0003645) | 2.29476075 |
| 91 | Syncope (HP:0001279) | 2.29358358 |
| 92 | Asplenia (HP:0001746) | 2.28822479 |
| 93 | Duodenal stenosis (HP:0100867) | 2.28604604 |
| 94 | Small intestinal stenosis (HP:0012848) | 2.28604604 |
| 95 | Prolonged neonatal jaundice (HP:0006579) | 2.28339228 |
| 96 | Prolonged QT interval (HP:0001657) | 2.28271814 |
| 97 | Retinal atrophy (HP:0001105) | 2.27986029 |
| 98 | Abnormality of midbrain morphology (HP:0002418) | 2.27606876 |
| 99 | Molar tooth sign on MRI (HP:0002419) | 2.27606876 |
| 100 | Duplicated collecting system (HP:0000081) | 2.26514338 |
| 101 | Mitochondrial inheritance (HP:0001427) | 2.26064450 |
| 102 | Abnormality of vitamin metabolism (HP:0100508) | 2.26050573 |
| 103 | Polydipsia (HP:0001959) | 2.25996313 |
| 104 | Abnormal drinking behavior (HP:0030082) | 2.25996313 |
| 105 | Abnormal hair whorl (HP:0010721) | 2.24642617 |
| 106 | Micronodular cirrhosis (HP:0001413) | 2.24439664 |
| 107 | Alveolar cell carcinoma (HP:0006519) | 2.24376616 |
| 108 | Poor suck (HP:0002033) | 2.22383526 |
| 109 | Absent thumb (HP:0009777) | 2.21950464 |
| 110 | Ureteral duplication (HP:0000073) | 2.19877942 |
| 111 | Abnormality of the renal medulla (HP:0100957) | 2.19311002 |
| 112 | Hyperlipoproteinemia (HP:0010980) | 2.18927898 |
| 113 | Xanthomatosis (HP:0000991) | 2.18435224 |
| 114 | Type I transferrin isoform profile (HP:0003642) | 2.17779522 |
| 115 | Abdominal situs inversus (HP:0003363) | 2.16776172 |
| 116 | Abnormality of abdominal situs (HP:0011620) | 2.16776172 |
| 117 | Supernumerary spleens (HP:0009799) | 2.14443160 |
| 118 | Abnormality of the renal collecting system (HP:0004742) | 2.14171884 |
| 119 | Type 2 muscle fiber atrophy (HP:0003554) | 2.14150719 |
| 120 | Muscle fiber atrophy (HP:0100295) | 2.13952264 |
| 121 | Muscular hypotonia of the trunk (HP:0008936) | 2.13895395 |
| 122 | Hypoglycemic coma (HP:0001325) | 2.12302852 |
| 123 | Bronchiectasis (HP:0002110) | 2.12096812 |
| 124 | Myelodysplasia (HP:0002863) | 2.11312978 |
| 125 | Absent radius (HP:0003974) | 2.07852655 |
| 126 | Abnormality of glycolipid metabolism (HP:0010969) | 2.07780624 |
| 127 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.07780624 |
| 128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.07780624 |
| 129 | EEG with generalized epileptiform discharges (HP:0011198) | 2.07132873 |
| 130 | Episodic fever (HP:0001954) | 2.06998283 |
| 131 | Abnormal EKG (HP:0003115) | 2.06878093 |
| 132 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.06080662 |
| 133 | Acute encephalopathy (HP:0006846) | 2.05549313 |
| 134 | Abnormality of T cell physiology (HP:0011840) | 2.05497713 |
| 135 | Gastrointestinal atresia (HP:0002589) | 2.04610007 |
| 136 | Abnormal biliary tract morphology (HP:0012440) | 2.04453350 |
| 137 | Embryonal renal neoplasm (HP:0011794) | 2.04287663 |
| 138 | Late onset (HP:0003584) | 2.03967980 |
| 139 | Polyphagia (HP:0002591) | 2.02658430 |
| 140 | Hypobetalipoproteinemia (HP:0003563) | 2.02304870 |
| 141 | Pustule (HP:0200039) | 2.01984920 |
| 142 | Hepatocellular necrosis (HP:0001404) | 2.01957045 |
| 143 | Cone-rod dystrophy (HP:0000548) | 2.01663175 |
| 144 | Increased CSF lactate (HP:0002490) | 2.00972331 |
| 145 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.00633402 |
| 146 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.97067477 |
| 147 | Hypsarrhythmia (HP:0002521) | 1.96121394 |
| 148 | Mitral stenosis (HP:0001718) | 1.95953348 |
| 149 | Epileptiform EEG discharges (HP:0011182) | 1.95818188 |
| 150 | Resting tremor (HP:0002322) | 1.95249969 |
| 151 | Subacute progressive viral hepatitis (HP:0006572) | 1.94834131 |
| 152 | Dysostosis multiplex (HP:0000943) | 1.94310873 |
| 153 | Renal Fanconi syndrome (HP:0001994) | 1.93490167 |
| 154 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.92449579 |
| 155 | Macroorchidism (HP:0000053) | 1.92439392 |
| 156 | Diminished movement (HP:0002374) | 1.92410146 |
| 157 | Abnormality of macrophages (HP:0004311) | 1.92216114 |
| 158 | Recurrent bacterial skin infections (HP:0005406) | 1.91882182 |
| 159 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.91043778 |
| 160 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.91043778 |
| 161 | Abnormality of renal resorption (HP:0011038) | 1.90407611 |
| 162 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.90119615 |
| 163 | Tongue fasciculations (HP:0001308) | 1.89992041 |
| 164 | Hypoglycemic seizures (HP:0002173) | 1.89296757 |
| 165 | Menstrual irregularities (HP:0000858) | 1.88973420 |
| 166 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.88482354 |
| 167 | Abnormality of DNA repair (HP:0003254) | 1.87575812 |
| 168 | Aplasia involving forearm bones (HP:0009822) | 1.87160367 |
| 169 | Absent forearm bone (HP:0003953) | 1.87160367 |
| 170 | Generalized aminoaciduria (HP:0002909) | 1.86370306 |
| 171 | Amelogenesis imperfecta (HP:0000705) | 1.86310260 |
| 172 | Pancreatic cysts (HP:0001737) | 1.86172973 |
| 173 | Hepatic necrosis (HP:0002605) | 1.86080125 |
| 174 | Basal ganglia calcification (HP:0002135) | 1.85135863 |
| 175 | Abnormality of the nasal mucosa (HP:0000433) | 1.84322479 |
| 176 | Submucous cleft hard palate (HP:0000176) | 1.82557095 |
| 177 | Increased hepatocellular lipid droplets (HP:0006565) | 1.81634756 |
| 178 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.81132345 |
| 179 | Hematochezia (HP:0002573) | 1.80362808 |
| 180 | Bone marrow hypocellularity (HP:0005528) | 1.80206274 |
| 181 | Autoimmune thrombocytopenia (HP:0001973) | 1.80192143 |
| 182 | Triphalangeal thumb (HP:0001199) | 1.79708650 |
| 183 | Decreased circulating renin level (HP:0003351) | 1.78871901 |
| 184 | Abnormality of the duodenum (HP:0002246) | 1.78521021 |
| 185 | Abnormality of the renal cortex (HP:0011035) | 1.77816363 |
| 186 | Bronchitis (HP:0012387) | 1.77636848 |
| 187 | Stomach cancer (HP:0012126) | 1.77616109 |
| 188 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.77297023 |
| 189 | Intestinal fistula (HP:0100819) | 1.76930950 |
| 190 | Abnormality of the umbilical cord (HP:0010881) | 1.76581458 |
| 191 | Enlarged kidneys (HP:0000105) | 1.75183206 |
| 192 | Abnormality of the fingertips (HP:0001211) | 1.73246457 |
| 193 | Reticulocytopenia (HP:0001896) | 1.72050920 |
| 194 | Pancreatic fibrosis (HP:0100732) | 1.69827164 |
| 195 | Broad nasal tip (HP:0000455) | 1.69770572 |
| 196 | Flat capital femoral epiphysis (HP:0003370) | 1.68621299 |
| 197 | Abnormal biliary tract physiology (HP:0012439) | 1.68384209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.64979663 |
| 2 | TXK | 5.34832493 |
| 3 | MAP3K12 | 4.60529376 |
| 4 | STK38L | 3.99955713 |
| 5 | MAP3K14 | 3.62710696 |
| 6 | DAPK2 | 2.53029832 |
| 7 | ACVR1B | 2.49900862 |
| 8 | EIF2AK1 | 2.45198784 |
| 9 | PHKG1 | 2.35760752 |
| 10 | PHKG2 | 2.35760752 |
| 11 | STK24 | 2.28149818 |
| 12 | ZAP70 | 2.25016331 |
| 13 | GRK1 | 2.21620162 |
| 14 | AKT3 | 2.17596909 |
| 15 | WNK3 | 2.17456191 |
| 16 | PIM2 | 2.02956844 |
| 17 | MAP4K2 | 1.94718720 |
| 18 | EPHA3 | 1.81312739 |
| 19 | MAP3K4 | 1.80156194 |
| 20 | INSRR | 1.77560573 |
| 21 | MAP4K1 | 1.75948555 |
| 22 | CDK3 | 1.74396237 |
| 23 | EIF2AK3 | 1.71558007 |
| 24 | FGFR2 | 1.68506246 |
| 25 | PAK3 | 1.66848188 |
| 26 | MAPK15 | 1.60410663 |
| 27 | MUSK | 1.57073886 |
| 28 | MST4 | 1.53132392 |
| 29 | TRIM28 | 1.52868032 |
| 30 | CSNK1G2 | 1.49092619 |
| 31 | FGFR3 | 1.48473902 |
| 32 | IKBKB | 1.43456163 |
| 33 | NEK9 | 1.41839225 |
| 34 | UHMK1 | 1.37834255 |
| 35 | CHUK | 1.35609553 |
| 36 | EIF2AK2 | 1.35409688 |
| 37 | ADRBK2 | 1.34410003 |
| 38 | NTRK3 | 1.33211242 |
| 39 | CDK12 | 1.30632309 |
| 40 | NLK | 1.30192115 |
| 41 | TBK1 | 1.24560687 |
| 42 | CAMKK2 | 1.22884680 |
| 43 | MAPK13 | 1.18794096 |
| 44 | IRAK2 | 1.18190582 |
| 45 | IKBKE | 1.17018769 |
| 46 | IRAK4 | 1.15170229 |
| 47 | JAK3 | 1.15009612 |
| 48 | MAP3K11 | 1.14801392 |
| 49 | BRAF | 1.13897908 |
| 50 | SRPK1 | 1.13508750 |
| 51 | STK10 | 1.13169842 |
| 52 | CSK | 1.11182479 |
| 53 | TESK1 | 1.11004191 |
| 54 | VRK1 | 1.09419391 |
| 55 | PTK2B | 1.08570366 |
| 56 | NTRK2 | 1.08178248 |
| 57 | MARK3 | 1.07101915 |
| 58 | IRAK1 | 1.05087022 |
| 59 | CAMK2D | 1.04991086 |
| 60 | TRPM7 | 1.02811286 |
| 61 | TEC | 1.02052949 |
| 62 | ITK | 1.01976154 |
| 63 | TTK | 1.01561979 |
| 64 | FGFR4 | 0.97105083 |
| 65 | DAPK1 | 0.96985911 |
| 66 | ARAF | 0.93913599 |
| 67 | MAP3K6 | 0.93467073 |
| 68 | TESK2 | 0.92888066 |
| 69 | PRKCG | 0.91756088 |
| 70 | PRKCI | 0.91125321 |
| 71 | PIM1 | 0.86910551 |
| 72 | BMPR1B | 0.86211909 |
| 73 | MYLK | 0.86108830 |
| 74 | MAP2K7 | 0.83977484 |
| 75 | MAP2K6 | 0.83953837 |
| 76 | PAK4 | 0.83479589 |
| 77 | BLK | 0.82741356 |
| 78 | LCK | 0.81600038 |
| 79 | MAPK7 | 0.81152971 |
| 80 | NEK1 | 0.80496557 |
| 81 | PINK1 | 0.80280641 |
| 82 | ERN1 | 0.78612909 |
| 83 | NEK6 | 0.77594430 |
| 84 | WNK4 | 0.77209850 |
| 85 | BMPR2 | 0.75405184 |
| 86 | STK3 | 0.74925338 |
| 87 | HIPK2 | 0.74154581 |
| 88 | TNK2 | 0.73890372 |
| 89 | MKNK2 | 0.72183574 |
| 90 | SGK2 | 0.71243611 |
| 91 | ZAK | 0.71091216 |
| 92 | GRK6 | 0.70638074 |
| 93 | RPS6KA4 | 0.70249869 |
| 94 | EPHB1 | 0.69784143 |
| 95 | DYRK3 | 0.67838095 |
| 96 | SYK | 0.67627664 |
| 97 | ICK | 0.66281351 |
| 98 | MAPK11 | 0.65056745 |
| 99 | LYN | 0.65003387 |
| 100 | TAOK3 | 0.64329331 |
| 101 | BTK | 0.64086002 |
| 102 | CAMK1G | 0.63605214 |
| 103 | CSNK1G1 | 0.63420029 |
| 104 | RPS6KL1 | 0.62978755 |
| 105 | RPS6KC1 | 0.62978755 |
| 106 | PNCK | 0.61920721 |
| 107 | ATR | 0.61545660 |
| 108 | PRPF4B | 0.61192558 |
| 109 | NEK2 | 0.60908053 |
| 110 | ERBB3 | 0.60097869 |
| 111 | GRK7 | 0.59515263 |
| 112 | PRKCQ | 0.59428661 |
| 113 | OXSR1 | 0.59072663 |
| 114 | CSNK1D | 0.58294715 |
| 115 | BRSK2 | 0.56958301 |
| 116 | STK38 | 0.56918143 |
| 117 | MAP3K13 | 0.56739540 |
| 118 | TAF1 | 0.56442039 |
| 119 | RPS6KA6 | 0.56119682 |
| 120 | RPS6KA5 | 0.55563035 |
| 121 | JAK1 | 0.55328216 |
| 122 | YES1 | 0.55039569 |
| 123 | SIK3 | 0.54542678 |
| 124 | GRK5 | 0.54540290 |
| 125 | PLK1 | 0.53115840 |
| 126 | TNIK | 0.52571242 |
| 127 | CASK | 0.52134490 |
| 128 | PRKG1 | 0.51784943 |
| 129 | PRKAA2 | 0.51050224 |
| 130 | NME1 | 0.49721206 |
| 131 | PRKCE | 0.49081183 |
| 132 | PRKD2 | 0.48962146 |
| 133 | EPHA2 | 0.48472002 |
| 134 | CHEK2 | 0.47031390 |
| 135 | ADRBK1 | 0.46778904 |
| 136 | MAP3K2 | 0.46486381 |
| 137 | CSNK1A1L | 0.45611634 |
| 138 | PRKG2 | 0.44330382 |
| 139 | STK11 | 0.43755024 |
| 140 | MAP3K5 | 0.43337575 |
| 141 | SGK494 | 0.42733694 |
| 142 | SGK223 | 0.42733694 |
| 143 | PRKCD | 0.42449999 |
| 144 | PDK1 | 0.42062973 |
| 145 | HCK | 0.42002577 |
| 146 | CSNK1G3 | 0.41636289 |
| 147 | PBK | 0.40314573 |
| 148 | EPHA4 | 0.40125483 |
| 149 | PLK2 | 0.40025490 |
| 150 | CDK7 | 0.40012537 |
| 151 | SGK3 | 0.39848963 |
| 152 | TSSK6 | 0.39527841 |
| 153 | PRKACB | 0.39463508 |
| 154 | WNK1 | 0.39405152 |
| 155 | CSNK1A1 | 0.38827233 |
| 156 | PRKACA | 0.37780039 |
| 157 | MAP2K4 | 0.37520163 |
| 158 | FER | 0.37391695 |
| 159 | PRKAA1 | 0.36634828 |
| 160 | PASK | 0.36430279 |
| 161 | STK39 | 0.36349119 |
| 162 | PRKCA | 0.34888214 |
| 163 | ROCK2 | 0.32733055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.95772887 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.16251331 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.14542435 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.01488359 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.88663436 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.71976983 |
| 7 | Insulin secretion_Homo sapiens_hsa04911 | 2.67097283 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.56906180 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.49849787 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.46677072 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.39896448 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.34623954 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.30377937 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.28437627 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.17609412 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.12806565 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.08527930 |
| 18 | Measles_Homo sapiens_hsa05162 | 2.00948411 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.98065626 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.95528719 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 1.86395970 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81294689 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.76864423 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.76025019 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.75740638 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.75444155 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.72641853 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69896962 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.69158776 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.60018855 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59252219 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.51398334 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.50225415 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.47635957 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46361874 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.45240553 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.45106023 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.44869555 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.38627047 |
| 40 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.34872424 |
| 41 | Protein export_Homo sapiens_hsa03060 | 1.32372536 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.30577103 |
| 43 | Base excision repair_Homo sapiens_hsa03410 | 1.28960353 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.28598606 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25259532 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.24503271 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22822334 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.22539128 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22533753 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.22522854 |
| 51 | Malaria_Homo sapiens_hsa05144 | 1.22405364 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.20936484 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 1.16740475 |
| 54 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.15805374 |
| 55 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.14135156 |
| 56 | Parkinsons disease_Homo sapiens_hsa05012 | 1.13393142 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.10669715 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10078214 |
| 59 | Circadian entrainment_Homo sapiens_hsa04713 | 1.08804799 |
| 60 | Phototransduction_Homo sapiens_hsa04744 | 1.04488060 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 1.04366493 |
| 62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02343901 |
| 63 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.02340042 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01186906 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.00307745 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.00109716 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98317676 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97457317 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.95576920 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.95068959 |
| 71 | RNA degradation_Homo sapiens_hsa03018 | 0.93812739 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.93598826 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89638899 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87738349 |
| 75 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.87567484 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87223936 |
| 77 | Proteasome_Homo sapiens_hsa03050 | 0.85651480 |
| 78 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.85037330 |
| 79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83713504 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.81648037 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81371662 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.81198890 |
| 83 | DNA replication_Homo sapiens_hsa03030 | 0.81160355 |
| 84 | Cell cycle_Homo sapiens_hsa04110 | 0.79611276 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79574841 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79510218 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.79448936 |
| 88 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77883424 |
| 89 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.77463794 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77406182 |
| 91 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76670676 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.76402433 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75286889 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.75215618 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74012998 |
| 96 | Tuberculosis_Homo sapiens_hsa05152 | 0.73093830 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72630388 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.71702498 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71584689 |
| 100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71418367 |
| 101 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70896022 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.70505234 |
| 103 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70447604 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69819298 |
| 105 | GABAergic synapse_Homo sapiens_hsa04727 | 0.68826261 |
| 106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.65949384 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.65883609 |
| 108 | Mismatch repair_Homo sapiens_hsa03430 | 0.65144726 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.65005374 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64713575 |
| 111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64445524 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63510700 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62406325 |
| 114 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62016272 |
| 115 | RNA polymerase_Homo sapiens_hsa03020 | 0.61874287 |
| 116 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.61412983 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61199335 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60848835 |
| 119 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60766656 |
| 120 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60014631 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59540488 |
| 122 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59474829 |
| 123 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58762073 |
| 124 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58715517 |
| 125 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58454804 |
| 126 | Cocaine addiction_Homo sapiens_hsa05030 | 0.56877711 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55060675 |
| 128 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.53993066 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53316882 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.53115291 |
| 131 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.52262994 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51820011 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50507908 |
| 134 | Long-term depression_Homo sapiens_hsa04730 | 0.50098466 |
| 135 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49535188 |
| 136 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48707026 |
| 137 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48502081 |
| 138 | Salivary secretion_Homo sapiens_hsa04970 | 0.48459623 |
| 139 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47994978 |
| 140 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47814441 |
| 141 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47475670 |
| 142 | RNA transport_Homo sapiens_hsa03013 | 0.47322731 |
| 143 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46694296 |
| 144 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46226770 |
| 145 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45919730 |
| 146 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.44740101 |
| 147 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.44282115 |
| 148 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43945943 |
| 149 | Adherens junction_Homo sapiens_hsa04520 | 0.43291147 |
| 150 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43111941 |
| 151 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42898595 |
| 152 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42210039 |
| 153 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42003549 |
| 154 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41091401 |
| 155 | Morphine addiction_Homo sapiens_hsa05032 | 0.40159709 |
| 156 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.36118014 |
| 157 | Spliceosome_Homo sapiens_hsa03040 | 0.35788536 |
| 158 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.35746088 |
| 159 | Ribosome_Homo sapiens_hsa03010 | 0.35302942 |
| 160 | Olfactory transduction_Homo sapiens_hsa04740 | 0.33369346 |
| 161 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33160136 |
| 162 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32021692 |
| 163 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30963118 |
| 164 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30652806 |
| 165 | Nicotine addiction_Homo sapiens_hsa05033 | 0.30214978 |
| 166 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.28950825 |
| 167 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28915890 |
| 168 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28154150 |
| 169 | Lysosome_Homo sapiens_hsa04142 | 0.27993730 |
| 170 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27179691 |
| 171 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.26269504 |
| 172 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25497156 |
| 173 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.23904133 |
| 174 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.23119431 |
| 175 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.20236627 |

